Follow
Helena Martí Soler
Helena Martí Soler
Instituto de Salud Global de Barcelona
Verified email at isglobal.org
Title
Cited by
Cited by
Year
Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study
R Heinzer, S Vat, P Marques-Vidal, H Marti-Soler, D Andries, N Tobback, ...
The Lancet Respiratory Medicine 3 (4), 310-318, 2015
20212015
Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997 y 2005
J Marrugat, R Elosua, H Martí
Revista Española de Cardiología 55 (4), 337-346, 2002
4092002
The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study
H Marti-Soler, C Hirotsu, P Marques-Vidal, P Vollenweider, G Waeber, ...
The lancet Respiratory medicine 4 (9), 742-748, 2016
2362016
Seasonality of cardiovascular risk factors: an analysis including over 230 000 participants in 15 countries
H Marti-Soler, C Gubelmann, S Aeschbacher, L Alves, M Bobak, ...
Heart 100 (19), 1517-1523, 2014
1542014
Seasonal variation of overall and cardiovascular mortality: a study in 19 countries from different geographic locations
H Marti-Soler, S Gonseth, C Gubelmann, S Stringhini, P Bovet, PC Chen, ...
PloS one 9 (11), e113500, 2014
1202014
Manejo del síndrome coronario agudo sin elevación del segmento ST en España. Estudio DESCARTES (Descripción del Estado de los Síndromes Coronarios Agudos en un Registro …
H Bueno, A Bardají, A Fernández-Ortiz, J Marrugat, H Martí, M Heras
Revista española de cardiología 58 (3), 244-252, 2005
112*2005
Prevalence and determinants of periodic limb movements in the general population
J Haba‐Rubio, H Marti‐Soler, P Marques‐Vidal, N Tobback, D Andries, ...
Annals of neurology 79 (3), 464-474, 2016
1082016
Sleep characteristics and cognitive impairment in the general population: the HypnoLaus study
J Haba-Rubio, H Marti-Soler, N Tobback, D Andries, P Marques-Vidal, ...
Neurology 88 (5), 463-469, 2017
922017
Prevalence of sleep apnoea syndrome in the middle to old age general population
R Heinzer, H Marti-Soler, J Haba-Rubio
The lancet Respiratory medicine 4 (2), e5-e6, 2016
922016
Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999
M Gil, H Martí, R Elosúa, M Grau, J Sala, R Masiá, G Pérez, P Roset, ...
Revista española de cardiología 60 (4), 349-356, 2007
782007
Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005
J Marrugat, R Elosua, H Martí
Revista espanola de cardiologia 55 (4), 337-346, 2002
772002
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
D Camprubí, A Almuedo-Riera, H Martí-Soler, A Soriano, JC Hurtado, ...
PloS one 15 (11), e0242184, 2020
702020
Secular trends of obesity and cardiovascular risk factors in a Mediterranean population
H Schröder, R Elosua, J Vila, H Marti, MI Covas, J Marrugat
Obesity 15 (3), 557-562, 2007
662007
Impact of sex and menopausal status on the prevalence, clinical presentation, and comorbidities of sleep-disordered breathing
R Heinzer, H Marti-Soler, P Marques-Vidal, N Tobback, D Andries, ...
Sleep medicine 51, 29-36, 2018
612018
Gender differences in management and outcome of patients with acute myocardial infarction
A Reina, M Colmenero, EA de Hoyos, F Arós, H Martí, R Claramonte, ...
International journal of cardiology 116 (3), 389-395, 2007
612007
Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry
M Heras, H Bueno, A Bardají, A Fernández-Ortiz, H Martí, J Marrugat
Heart 92 (11), 1571-1576, 2006
55*2006
Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus
J Mwinyi, A Boström, I Fehrer, A Othman, G Waeber, H Marti-Soler, ...
PloS one 12 (5), e0175776, 2017
532017
Prevalence and characteristics of positional sleep apnea in the HypnoLaus population-based cohort
R Heinzer, NJ Petitpierre, H Marti-Soler, J Haba-Rubio
Sleep medicine 48, 157-162, 2018
512018
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes
R Klingenberg, S Aghlmandi, C Liebetrau, L Räber, B Gencer, D Nanchen, ...
European heart journal 38 (47), 3493-3502, 2017
502017
Multiple imputation analysis of case–cohort studies
H Marti, M Chavance
Statistics in medicine 30 (13), 1595-1607, 2011
492011
The system can't perform the operation now. Try again later.
Articles 1–20